In colorectal cancer, METTL3 methylates SOX2 mRNA, allowing it to bind to the mRNA-binding protein IGF2BP2 at m6A sites, preventing SOX2 mRNA degradation and promoting protein expression [37]. The gene discussed is IGF2BP2; the disease is colorectal cancer.